BATON ROUGE- Critics across the country are wondering why Dsuvia is needed. This is a new opioid and painkiller, which has recently given a FDA approval mark, but many disagree and think this is a terrible mistake.
"We are in the midst of possibly the worst epidemic, an innocent epidemic in this country that will probably kill and injure more people than any other epidemic, such as the state, or the world has seen," said Coroner Beau Clark.
East Baton Rouge Parish Coroner, Dr.Beau Clark saw first hand the fatal effects of the use of opioids with at least 72 deaths due to overdoses in the parish only this year.
"This seems to be a clear manifest disregard for human life. We are talking about substance opioids that kill people, why we need more when we have problems with what we have," Clark said.
According to the FDA, there are strict guidelines for a drug that dissolves in the mouth. It can only be used in hospitals, surgical centers and emergency rooms. Duvivia should not be used for more than 72 hours and is not available in retail pharmacies.
They say this is a drug that will be used only in a health center for a very short period in a highly controlled environment. That's great, if that's the case. However, later in the statement they say that this was also developed by the Ministry of Defense, which is why it is contrary to that.
Dr. Scott Gottlieb, in a statement from the FDA, said: "This opioid formulation along with the unique Duvia delivery device was the Pentagon's preferred product because it fills a specific and vital, but limited, insufficient need to treat our national soldiers for battle, but Dr. Clark does not buys.
"A soldier is outside to protect our country, and if they are injured on the battlefield, we must have mechanisms for dealing with pain, especially if they have a long transport time, from where they are being injured and taken care of, but I think that these things already exist" Clark said.
Serious risks of using Dsuvia are respiratory depression, coma and even death, and we do not mention very addictive.
"With stronger and stronger opioids, it's really the wrong direction and definitely sends the wrong message." In a statement by dr. Gottlieb on Dewey added: "We will not mislead what I believe is a true source of dissatisfaction among critics of this consent, the question of whether or not America needs another powerful opioid, or not, while in a great crisis of addiction."
Gottlieb says this issue will be open and directly addressed. Dsuvia is expected to sell $ 1.1 billion annually, while Clark is more concerned with life that could be lost in the future.
"We are on the way to the second record year of an increase in the number of opioids compared to last year, and I see no end in sight, and when we do something like that, we are creating another category of even stronger Opioids I think it leads to more and more problems," he said Clark.
For more information about Dwvia click here.